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Abstract

Background: Our group has shown a positive dose-response in maximal cardiorespiratory exercise capacity (VO2max)
and heart rate variability (HRV) to 6 months of exercise training but no improvement in VO2max for women ‡ 60 years.
Here, we examine the HRV response to exercise training in postmenopausal women younger and older than 60 years.
Methods: We examined 365 sedentary, overweight, hypertensive, postmenopausal women randomly assigned
to sedentary control or exercise groups exercising at 50% (4 kcal/kg/week, [KKW]), 100% (8 KKW) and 150% (12
KKW) of the National Institutes of Health (NIH) Consensus Development Panel physical activity guidelines.
Primary outcomes included time and frequency domain indices of HRV.
Results: Overall, our analysis demonstrated a significant improvement in parasympathetic tone (rMSSD and
high frequency power) for both age strata at 8 KKW and 12 KKW. For rMSSD, the age-stratified responses were:
control, < 60 years, 0.20 ms, 95% confidence interval (CI) - 2.40, 2.81; ‡ 60 years, 0.07 ms, 95% CI - 3.64, 3.79;
4 KKW, < 60 years, 3.67 ms, 95% CI 1.55, 5.79; ‡ 60 years, 1.20 ms, 95% CI - 1.82, 4.22; 8-KKW, < 60 years,
3.61 ms, 95% CI 0.88, 6.34; ‡ 60 years, 5.75 ms, 95% CI 1.89, 9.61; and 12-KKW, < 60 years, 5.07 ms, 95% CI 2.53,
7.60; ‡ 60 years, 4.28 ms, 95% CI 0.42, 8.14.
Conclusions: VO2max and HRV are independent risk factors for cardiovascular disease (CVD) mortality. Despite
no improvement in VO2max, parasympathetic indices of HRV increased in women ‡ 60 years. This is clinically
important, as HRV has important CVD risk and neurovisceral implications beyond cardiorespiratory function.

Introduction

T

he risk for cardiovascular disease (CVD) increases
in women after menopause.1 As with men, maximal
cardiorespiratory exercise capacity (VO2max) is protective
against CVD in women.2 Accordingly, interventions aimed at
improving maximal cardiorespiratory capacity carry with
them a 13% reduction in CVD risk accompanying each increase in maximal metabolic equivalent (MET).3 Alterations
in the autonomic nervous system, as measured by heart rate
variability (HRV), are also independently associated with
CVD and all-cause mortality.4,5 This relationship is important,
as autonomic balance portrays the relationship between the
parasympathetic and sympathetic nervous systems and is
intricately connected to many factors affecting cardiovascular
function.6,7 As it pertains to aging, both maximal cardiorespiratory capacity and HRV decrease after menopause, yet
both are positively affected by exercise training.1,8
In a recent report detailing the primary outcomes of a large
clinical trial involving exercise training in postmenopausal

women, the Dose Response to Exercise in Women (DREW)
trial, we demonstrated a significant dose-dependent improvement in VO2max in postmenopausal women after 6
months of exercise at *50%, 100%, and 150% of the National
Institute of Health’s (NIH) Consensus Development Panel
recommendation for exercise.9,10 In a series of ancillary reports, we showed that exercise training also improved HRV
and that those with improved HRV also showed improvements in circulating insulin.12,13 This latter observation is
important because the autonomic nervous system is intricately linked to numerous systemwide physiologic functions,
including, but not limited to, mood, depression, indices of
anthropometry, respiration, digestion, sexual arousal, cognitive and executive functioning, and vagal control of the cardiovascular system.11–17 Therefore, it is conceivable that
autonomic balance and VO2max may be affected differently
from one another concomitant to exercise training.
The answer to this question is important to the aging process in women, as in one of our ancillary reports stratified by
age, we found that regardless of exercise dose, women aged
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> 60 showed an attenuated response in VO2max to exercise
training, where the extent that VO2max changed was not
deemed statistically significant.18 Based on this finding, some
may question the utility of recommending low-to-moderate
exercise in an older population if VO2max is held as the gold
standard determinant of exercise training efficacy. However,
we believe that VO2max is the resultant sum of numerous
physiologic system adaptations. It should also hold that
any component associated with systemwide improvements may also be affected by exercise participation even if
maximal VO2max is not.19,20 It is, therefore, conceivable that
HRV may improve in older participants independent of a
change in VO2max. Although several small sample studies
have shown an improvement in HRV accompanying an exercise intervention in older participants, no such data exist in
larger interventions using carefully monitored doses of exercise energy expenditure.21–23 Given our collective observations with DREW, we asked the question whether women
‡ 60 years who exhibit an attenuated response in VO2max also
show a similar attenuation in their HRV response to exercise
training.
Materials and Methods
Study design
The complete design, methods, and primary outcomes of
our study are presented elsewhere.9,24 Briefly, the DREW
study was a randomized, dose-response exercise training trial
complying with the Declaration of Helsinki comparing a
nonexercise control group with three groups exercising at
incremental doses (50%, 100%, and 150%) of the minimal NIH
Consensus Development Panel’s recommendation for energy
expenditure.10 The Cooper Institute and Pennington Biomedical Research Center’s institutional review boards reviewed
DREW annually. The primary outcomes for the DREW study
included VO2max based on the average of two baseline and
two follow-up exercise tests and resting blood pressure. Ancillary studies have examined HRV as well as the VO2max
response of women in various age groups.18–20
Participants
After an initial evaluation and run-in period, we randomized 464 postmenopausal women (45–75 years) to one of three
exercise groups or a nonexercise control group for a 6-month
intervention period. The exercise intensity for this study was
fixed at 50% of measured VO2max, which is considered to be
low-to-moderate exercise intensity. During the exercise portion of the study, there were distinct and separate intervention
and assessment teams, and all assessment staff were blinded
to participant randomization assignment. The exercise testing
and exercise training laboratories were on separate floors of
the building. We regularly reminded participants not to discuss their randomization assignments with assessment team
members.
Study participants were sedentary (exercising < 20 minutes, < 3 days/weeks, < 8000 steps/day assessed over the
course of 1 week), overweight or obese (body mass index
[BMI] 25.0–43.0 kg/m2), and had a systolic blood pressure of
120–160 mm Hg. We excluded women who had a history of
stroke, heart attack, or any serious medical condition that
prevented them from adhering to the protocol or exercising
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safely. Our current analysis is limited to 365 women who
successfully completed both VO2max and HRV testing. Of
these, 118 women were ‡ 60 years. After baseline testing,
which included HRV measurements, participants were randomized to their respective treatment groups.
Heart rate variability
Although many indices of HRV exist, the time and frequency domain indices are the most common. For the time
domain, the root mean square of successive RR intervals
(rMSSD) represents parasympathetic nervous system activity,
and the standard deviation of normal beat-to-beat (RR) intervals (SDNN) is a global index encompassing both the sympathetic and parasympathetic nervous systems. For the
frequency domain, high frequency (HF, 0.15–0.40 Hz) power
has been linked to vagal activity, whereas the role of other
indices is less clear.6 Nonetheless, we also calculated additional frequency domain spectra, such as low frequency power
(LF, 0.04–0.15 Hz), very low frequency power (VLF, 0.0033–
0.04 Hz), and total frequency power (PT, 0.00–0.40 Hz).
We examined each participant’s HRV between 6:30 am and
11:00 am for 25 minutes in a semidark room at 22–23C after a 12hour fast inclusive of abstinence from caffeine and alcohol (12
hour) and exercise (48 hour). We controlled each participant’s
respiration rate using a metronome at a fixed rate of 12 breaths
per minute (0.2 Hz). The RR interval measurements were conducted at the same time ( – 1 hour) of day for each participant
during the baseline and posttest assessment periods. To assess
HRV, we used a two-channel ECG signal detected by a Polar
Heart Rate Monitor transmitted online to a PC through Polar
Advantage Interface receiver. All data were filtered to eliminate
ectopic beats and artifacts. Additionally, an RR interval tachogram was displayed for manual editing, and areas of ectopy or
artifacts were identified and removed by manual deletion. Each
edited RR interval was replaced with an average value. Segments containing > 15% of edited RR intervals were interpreted
as premature beats and were excluded from data analysis.25
Statistical analysis
We used a generalized linear model to analyze the influences of the differing doses of exercise training on HRV
characteristics. We focused our primary analysis on the time
domain index of rMSSD, as it is sensitive to short periods of
recording time.6 We also examined the frequency domain
index HFLn as a means of examining parasympathetic activity. We adjusted all our outcomes among the randomization
groups for select specified covariates, including baseline
HRV, race, and use of antidepressant medication. Given that
this is an ancillary analysis in a large cohort, we first reproduced the findings of our primary outcome study and
other ancillary reports from which we formed our current
research question. The results were consistent, so we undertook further analysis to answer the question of whether age
affects HRV improvements associated with exercise training.
To accomplish this, we subdivided women by age into those
< 60 years and ‡ 60 years of age, given our recent report
showing that this latter age group was unresponsive to
exercise training as determined by changes in Vo2max.18
Within-group differences between baseline and follow-up are
reported as mean and 95% confidence intervals (95% CI).
Knowing that age was significant for baseline Vo2max.from
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our previous report, we added baseline Vo2max.as a covariate
to our analysis to examine if lower fitness levels at the start of
training influenced our current analyses. If present, age group
interactions were explored for pairwise comparisons between
the exercise training groups vs. the control group using a
Dunnett-Hsu post-hoc assessment. The Dunnett-Hsu test allows for specific multiple pairwise comparisons while still
protecting against type I statistical errors. Between-group
differences at baseline and follow-up in prevalence were examined using chi-square tests. All reported p values are twosided ( p < 0.05). All analyses were performed using SPSS
version 19.0 (Somers, NY).
Results
We show the clinical and demographic data for our cohort
in Table 1. Similar to our previous reports, we observed that
VO2max increased significantly with increasing exercise dose
of exercise: control, - 2.86 mL/kg/min, 95% CI - 0.67,0.10);
4 kcal/kg/weeks, (KKW) 0.64 mL/kg/min, 95% CI 0.35, 0.98;
8 KKW, 1.41 mL/kg/min, 95% CI 1.01, 1.81; and 12 KKW,
1.60 mL/kg/min, 95% CI 1.22, 1.98. The rMSSD of HRV reflecting parasympathetic activity, also increased (Fig. 1A).

These results were confirmed by our analysis of HFLn. We also
observed that when stratified by age, VO2max was lower in
participants ‡ 60 years ( p < 0.001) and that women > age 60
did not demonstrate a significant improvement in VO2max
regardless of exercise dose. Based on these confirmatory
findings for our previous reports, we further explored the age
subgroup analysis finding that each time and frequency domain measurement of HRV was significantly lower in women
‡ 60 years ( p < 0.02). After exercise training, however, we
observed that rMSSD (Fig. 1B) and HFLn both improved significantly in the 8 KKW and 12 KKW groups regardless of age.
Although women < 60 years showed a significant improvement for these two parameters after 4 KKW exercise training
exposure, women ‡ 60 years did not. None of our findings
were influenced by baseline VO2max ( p = 0.2).
Discussion
The primary finding from our study demonstrates that
low-to-moderate intensity exercise training increases parasympathetic activity in previously sedentary, overweight or
obese, postmenopausal women regardless of age. Of particular importance to our findings is the observation that

Table 1. Baseline Demographic and Clinical Characteristics of Study Participants
All (n = 365)

Age, years
Hematology
Total cholesterol (mmol/L)
HDL (mmol/L)
LDL (mmol/L)
Glucose (mmol/L)
hsCRP (nmol/L)
Anthropometry
Height (cm)
Weight (kg)
BMI (kg/m2)
Waist circumference (cm)
Hip circumference (cm)
Blood pressure
Resting heart rate (b/min)
Systolic BP (mm Hg)
Diastolic BP (mm Hg)
Cardiovascular
Vo2max (mL/kg/min)
Vo2max (L/min)
Maximum RER
Maximum heart rate (b/min)
Time domain for HRV (ms)
rMSSD
SDNN
Frequency domain for HRV (ms2)
TotalLn
VLFLn
LFLn
HFLn

< 60 years (n = 247)

‡ 60 years (n = 118)

Mean

SD

Mean

SD

Mean

SD

57.52

6.2

54.06

3.5

64.80

4.2

5.23
1.49
3.05
5.27
53.83

0.78
0.37
0.69
0.55
53.67

5.27
1.48
3.07
5.27
54.11

0.76
0.36
0.69
0.50
53.79

5.13
1.52
3.00
5.29
53.19

0.81
0.40
0.71
0.64
55.21

162.80
83.99
31.63
100.70
114.71

5.8
11.8
3.7
11.4
9.1

163.34
85.02
32.23
99.96
114.78

5.8
11.9
5.7
10.6
8.9

161.96
82.56
31.44
102.56*
114.86

5.8
11.7
3.8
12.6
9.3

139.56
80.90

13.2
8.5

138.56
82.28

12.8
8.2

141.74
78.03

13.8
8.6

15.59
1.30
1.13
151

2.9
0.3
0.1
16

16.08
1.36
1.14
155

2.9
0.2
0.9
15

14.45*
1.24*
1.14
144*

2.6
0.2
0.1
17

22.99
32.87

11.7
11.5

23.99
34.18

11.55
11.72

20.91*
30.14*

11.74
10.59

6.26
4.62
5.29
5.12

0.8
0.8
0.9
1.1

6.37
4.69
5.38
5.25

0.8
0.83
0.89
1.04

6.03*
4.45*
5.10*
4.84*

0.9
0.81
0.97
1.13

*Significantly different from < 60 years.
BMI, body mass index; HDL, high-denisty lipoprotein; HRV, heart rate variability; hsCRP, high sensitivity c-reactive protein; LDL, lowdensity lipoprotein; LF, low frequency; RER, respiratory exchange ratio; rMSSD, root mean square of successive beat-to-beat intervals; SD,
standard deviation; SDNN, SD of normal RR intervals; VO2max, maximal cardiorespiratory exercise capacity.
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FIG. 1. Data represent changes
the root mean square of successive
RR intervals (rMSSD) indicative of
changes in parasympathetic nervous system activity for the entire
Dose Response to Exercise in Women (DREW) cohort (A) and when
stratified by age (B) denoting
younger ( < 60 years) and older
( ‡ 60 years) women. KKW, kcals/
kg/week.

women ‡ 60 years of age showed a significant improvement
in HRV despite demonstrating no improvement in VO2max.
Unfortunately, a consensus of findings from exercise intervention trials in older individuals is difficult, as the literature
to date is either cross-sectional, longitudinal, or based on
conflicting results from studies using small sample sizes. In
cross-sectional studies, older women undertaking high levels
of physical activity ( > 2000 kcal/week) demonstrate higher
levels of parasympathetic HRV activity than women with
lower daily energy expenditures.26 A report from the Whitehall II cohort study examining how predictive variables of
HRV change over time were associated with baseline behavioral, biologic, and social and psychosocial factors showed
that age-adjusted and gender-adjusted participants who
avoided the lowest (i.e., most adverse) quartile of HRV
function were most influenced by baseline levels of exercise,
BMI, cholesterol, and blood pressure.

Regarding exercise interventions, Davy et al.23 reported in
8 postmenopausal women that HRV did not improve after 12
weeks of aerobic exercise at 70% of maximal heart rate. In
contrast, Stein et al.22 demonstrated an improvement in HRV
characteristics for older women exercising for 12 months, and
Albinet et al.21 recently showed that HRV increased in older
men and women after 12 weeks of exercise training. Still, these
latter two studies comprised 18 and 13 women, respectively,
who were further divided into two treatment groups. Although the results of these early exercise intervention trials
suggest that the effects of exercise on HRV may be equivocal,
we are now able to confirm the findings of the those studies
showing a positive modulation in autonomic nervous system
activity accompanying exercise training in a large cohort of
women ‡ 60 years of age. The findings of our study are clinically important because the autonomic nervous system
function is associated not only with CVD risk but also with a
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number of health-related issues, such as mood, depression,
anthropometry, extreme physical exertion, cognitive and executive functioning, and vagal control of the cardiovascular
system.6,11–17,27
Overall, parasympathetic activity is higher in women
than men, yet aging reduces this difference in that parasympathetic activity shifts to a lower range after menopause.28–32 Heart rate variability (HRV) is a good example
of how the risk for CVD may be improved with exercise
during aging as a result of changes in systems physiology
independent of improvements in VO2max. For example, exercise training positively affects cognitive performance and
executive function in older adults.33 This may be due in part
to the observation that impaired cognitive performance,
prefrontal brain control, and symptoms of depression in
older women have been associated with vagal function.33–37
Thus, the improvement in parasympathetic activity in our
study as higher HF power is associated with better cognitive
performance, whereas low HF power is predictive of cognitive impairment in aging women.14,15,35 The role of exercise
also appears to be important, as Albinet et al.21 recently
demonstrated that 12 weeks of exercise significantly improved vagal-mediated indicators of HRV, specifically
rMSSD, as well as cognitive function, as measured by the
Wisconsin card sorting test. Although the direct link between
exercise training and cognitive function is still unclear, it has
been suggested that modulation of cardiac activity by the
prefrontal cortex is vagally mediated and part of the neurovisceral-integrated relationship between central and peripheral nervous system interactions.36,38,39
A primary strength of the DREW study is that it was a
large, well-controlled exercise training study with excellent
exercise adherence and a low dropout rate. The DREW study
was also well positioned to answer the research question that
we have posed given the large number of women ‡ 60 years
in our study. The DREW study has limitations because its
sample is limited to sedentary, overweight or obese, postmenopausal women at a moderately elevated risk of CVD.
Therefore, we do not know if the results will apply to other
women or to men. Additionally, although the results of our
study show that postmenopausal women can improve their
HRV with exercise without improving VO2max, the clinical
importance of our findings relative to future health habitus
remains unclear. Furthermore, we did not measure cognitive
function in DREW. Thus, we accept that the potential link
between improved HRV and cognitive function is theoretical
and not fully answerable at this time but should be considered
as a candidate measurement in future studies examining exercise and aging in both men and women.
The important point, however, is that our current findings strongly suggest that HRV is improved in older women partaking in a low-to-moderate intensity exercise
program irrespective of changes in VO2max. Although we
did not observe an HRV improvement in women > 60 years
for the 4 KKW group, we also did not find improvement by
exercising at an exercise dose > 8 KKW. Specifically, 8
KKW is equal to levels of exercise recommended by the
NIH Development Consensus Panel for exercise,9,10 Which
are easily attainable by most people. The results of our
study should help those involved in disseminating exercise
advice to refine their recommendations depending on the
goals of their patients.
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